Purpose To investigate a risk stratification strategy for lesions of uncertain malignant
potential (B3) diagnosed by vacuum-assisted breast biopsy (VABB) of mammographic …

Purpose To investigate clinical, radiologic and pathologic features of B3 lesions diagnosed
on VABB targeting microcalcifications, for identifying predictors of malignancy. Method This …

Purpose We retrospectively investigated clinical, radiological, and pathological features of
B3 lesions associated with the risk of subsequent upgrade to malignancy. Methods: We …

Purpose Breast lesions classified as of “uncertain malignant potential” represent a
heterogeneous group of abnormalities with an increased risk of associated malignancy …

Background and aim The use of conventional needle core biopsy for palpable masses and
vacuum-assisted needle core biopsy for microcalcifications has significantly increased the …

AIM To review all cases of B3 lesion diagnosed at initial image-guided needle biopsy over
two 5-year cohorts to identify upgrade rates to malignancy and the effect of changing …

Background: The question of how to deal with B3 lesions is of emerging interest. Methods: In
the breast diagnostics of 192 patients between 2009 and 2016, a minimally invasive biopsy …

Introduction Lesions of uncertain malignant potential (B3) represent 10% of core needle
biopsies (CNBs) or vacuum-assisted breast biopsies (VABBs). Traditionally, B3 lesions are …

In the setting of breast cancer screening, 5–9% of needle core biopsies are diagnosed as
lesions of uncertain malignant potential (B3). The management of these lesions is potentially …

Introduction Lesions of uncertain malignant potential (B3) represent a heterogeneous group
with an overall risk for malignancy of 9.85–35.1% after total resection. Positive predictive …